Clinical study of effects of Jian Ji Ning, a Chinese herbal medicine compound preparation, in treating patients with Myasthenia gravis via the regulation of differential MicroRNAs expression in serum

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Jiang, Chao ^a   Liu, Ping ^a   Zhang, Jingsheng ^b   Bao, Wenjing ^b   Qiu, Shaobo ^a   Liang, Yan ^a   Jiang, Lin ^c  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; JIAN JI NING; MICRORNA; MICRORNA 107; MICRORNA 109B 5P; MICRORNA 149 5P; MICRORNA 15B 5P; MICRORNA 16 5P; MICRORNA 17 5P; MICRORNA 20A 5P; MICRORNA 20B 5P; MICRORNA 665; MICRORNA 766 3P; MICRORNA 7A 5P; MICRORNA 7B 5P; MICRORNA 7C; MICRORNA 7D 5P; MICRORNA 7I 5P; MICRORNA 93 5P; MICRORNA 940; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENE TARGETING; GENETIC SCREENING; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

EID: 84896066833     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/518942     Document Type: Article

References (51)

1. Zouvelou V., Rentzos M., Toulas P., Evdokimidis I., AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy. Journal of Clinical Neuroscience 2012 19 6 918 919 2-s2.0-84856792888 10.1016/j.jocn.2011.09.022
2. McGrogan A., Sneddon S., de Vries C. S., The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010 34 3 171 183 2-s2.0-75549086673 10.1159/000279334
3. Giraud M., Vandiedonck C., Garchon H.-J., Genetic factors in autoimmune myasthenia gravis. Annals of the New York Academy of Sciences 2008 1132 10 180 192 2-s2.0-45249120631 10.1196/annals.1405.027 (Pubitemid 351841369)
4. Cavalcante P., Barberis M., Cannone M., Baggi F., Antozzi C., Maggi L., Cornelio F., Barbi M., Didò P., Berrih-Aknin S., Mantegazza R., Bernasconi P., Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis. Neurology 2010 74 14 1118 1126 2-s2.0-77950988479 10.1212/WNL.0b013e3181d7d884
5. Stefansson K., Dieperink M. E., Richman D. P., Marton L. S., Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis. Annals of the New York Academy of Sciences 1987 505 451 460 2-s2.0-0023621718
6. Mantegazza R., Bonanno S., Camera G., Antozzi C., Current and emerging therapies for the treatment of myasthenia gravis. Neuropsychiatric Disease and Treatment 2011 7 1 151 160 2-s2.0-80053634167 10.2147/NDT.S8915
7. Tüzün E., Huda R., Christadoss P., Complement and cytokine based therapeutic strategies in myasthenia gravis. Journal of Autoimmunity 2011 37 2 136 143 2-s2.0-80052668260 10.1016/j.jaut.2011.05.006
8. Chien P. J., Yeh J. H., Chiu H. C., Hsueh Y. M., Chen C. T., Chen M. C., Shih C. M., Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis. European Journal of Neurology 2011 18 11 1350 1357 2-s2.0-80053908160 10.1111/j.1468-1331.2011. 03424.x
9. García-Carrasco M., Escárcega R. O., Fuentes-Alexandro S., Riebeling C., Cervera R., Therapeutic options in autoimmune myasthenia gravis. Autoimmunity Reviews 2007 6 6 373 378 2-s2.0-34249705331 10.1016/j.autrev.2007. 01.001 (Pubitemid 46824097)
10. Lin H., Liu J., Zhang Y., Developments in cancer prevention and treatment using traditional Chinese medicine. Frontiers of Medicine 2011 5 2 127 133 2-s2.0-82355165064 10.1007/s11684-011-0137-7
11. Liu Z. L., Liu J. P., Zhang A. L., Wu Q., Ruan Y., Lewith G., Visconte D., Chinese herbal medicines for hypercholesterolemia. Cochrane Database of Systematic Reviews 2011 6 7 CD008305 2-s2.0-79960996398
12. He D. Y., Dai S. M., Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Frontiers in Pharmacology 2011 10 2 10.3389/fphar.2011.00010
13. Sun Y., Zang Z., Xu X., Zhang Z., Zhong L., Zan W., Zhao Y., Sun L., Experimental investigation of the immunoregulatory and anti-inflammatory effects of the traditional Chinese medicine "Li-Yan Zhi-Ke Granule" for relieving chronic pharyngitis in rats. Molecular Biology Reports 2011 38 1 199 203 2-s2.0-78651099528 10.1007/s11033-010-0095-1
14. Pan W., Kwak S., Liu Y., Sun Y., Fang Z., Qin B., Yamamoto Y., Traditional chinese medicine improves activities of daily living in parkinson's disease. Parkinson's Disease 2011 2011 7 2-s2.0-79959249316 10.4061/2011/789506 789506
15. Zhang J.-S., Sun W., Liu P., Liu H.-W., Yi T.-N., Influence of Huangqi compound on ultrastructure of neuromuscular junction in model rat of experimental autoimmune myasthenia gravis. Chinese Journal of Clinical Rehabilitation 2006 10 35 20 22 2-s2.0-33846373281 (Pubitemid 46128035)
16. Liu P., Zhang J. S., Han B., The regulation effects of Huangqi compound on the level of IFN-Y and it's mRNA in myasthenia gravis patients. Chinese Archives of Traditional Chinese Medicine 2004 22 11 2021 2022
17. Liu P., Ding X. F., Zhang Y. Y., Effect of Jianji Ning recipe on the differential expressive proteins in thymus with trial autoimmune myasthenia gravis. Chinese Archives of Traditional Chinese Medicine 2008 26 1 6 69
18. Liu P., Ding X.-F., Zhang Y.-Y., Qiao J., Modulation of Jianjining recipe on differential protein expression in rats with experimental autoimmune myasthenia gravis. Journal of Chinese Integrative Medicine 2007 5 6 642 646 2-s2.0-36549085611 10.3736/jcim20070608 (Pubitemid 350186611)
19. Liu P., Zhang J. S., Zheng F., The Regulating effects of Huangqi compound acetylcholine receptor antibody in patients with myasthenia gravis. Chinese Journal of Neuroimmunology and Neurology 2005 12 2 76 78
20. Sun X., Niu G. H., Zhang J. S., Effect of compound Astragalus membranaceus on Thl, Th2, Tcl and Tc2 subsets in peripheral blood of patients with myasthenia gravis. Medical Journal of the Chinese People's Armed Police Forces 2010 21 5 420 422
21. Niu G.-H., Sun X., Zhang C.-M., Effect of compound astragalus recipe on lymphocyte subset, immunoglobulin and complements in patients with myasthenia gravia. Chinese Journal of Integrated Traditional and Western Medicine 2009 29 4 305 308 2-s2.0-77952783232
22. Bao W. J., Zhang J. S., Qiao W. J., The study of Huangqi compound treatment on 73 cases of myasthenia gravis. Guangming Journal of Chinese Medicine 2008 23 2 208 209
23. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by MicroRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
24. van Rooij E., Olson E. N., MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. The Journal of Clinical Investigation 2007 117 9 2369 2376 2-s2.0-34848838292 10.1172/JCI33099 (Pubitemid 47494334)
25. Jiang L., Cheng Z., Qiu S., Altered let-7 expression in myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells. International Immunopharmacology 2012 14 2 217 223
26. Osserman K. E., Myasthenia Gravis 1958 New York, NY, USA Grune & Stratton Group
27. Chen H. Z., Practical Internal Medicine 2001 Beijing, China People's Medical Publishing Press
28. Zhang B. Y., Traditional Chinese Internal Medicine 1985 Shanghai, China Shanghai Science and Technology Press
29. Chinese Immunological Society of Neuroimmunology Branch, Chinese Medical Association Society of Neuropathy Branch of Neuroimmunology Unit, Myasthenia gravis diagnosis and treatment of the Chinese expert consensus. Chinese Journal of Neuroimmunology and Neurology 2012 19 6 401 408
30. Hirano T., Oka K., Umezawa Y., Hirata M., Oh-i T., Koga M., Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis. Clinical Pharmacology and Therapeutics 1998 63 4 465 470 2-s2.0-0031926343 10.1016/S0009-9236(98)90042-X (Pubitemid 28214970)
31. Wright G. W., Simon R. M., A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003 19 18 2448 2455 2-s2.0-0348143180 10.1093/bioinformatics/btg345 (Pubitemid 38016644)
32. Yang H., Crawford N., Lukes L., Finney R., Lancaster M., Hunter K. W., Metastasis predictive signature profiles pre-exist in normal tissues. Clinical and Experimental Metastasis 2005 22 7 593 603 2-s2.0-32544456277 10.1007/s10585-005-6244-6 (Pubitemid 43234644)
33. Clarke R., Ressom H. W., Wang A., Xuan J., Liu M. C., Gehan E. A., Wang Y., The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nature Reviews Cancer 2008 8 1 37 49 2-s2.0-37549029793 10.1038/nrc2294
34. Xiao S., Mo D., Wang Q., Jia J., Qin L., Yu X., Niu Y., Zhao X., Liu X., Chen Y., Aberrant host immune response induced by highly virulent PRRSV identified by digital gene expression tag profiling. BMC Genomics 2010 11 1, article 544 2-s2.0-77957356729 10.1186/1471-2164-11-544
35. Miller L. D., Long P. M., Wong L., Mukherjee S., McShane L. M., Liu E. T., Optimal gene expression analysis by microarrays. Cancer Cell 2002 2 5 353 361 2-s2.0-0012949538 10.1016/S1535-6108(02)00181-2 (Pubitemid 41039101)
36. Ramoni M. F., Sebastiani P., Kohane I. S., Cluster analysis of gene expression dynamics. Proceedings of the National Academy of Sciences of the United States of America 2002 99 14 9121 9126 2-s2.0-0037047161 10.1073/pnas.132656399 (Pubitemid 34764577)
37. Schlitt T., Palin K., Rung J., Dietmann S., Lappe M., Ukkonen E., Brazma A., From gene networks to gene function. Genome Research 2003 13 12 2568 2576 2-s2.0-0346752107 10.1101/gr.1111403 (Pubitemid 37541145)
38. Dupuy D., Bertin N., Hidalgo C. A., Venkatesan K., Tu D., Lee D., Rosenberg J., Svrzikapa N., Blanc A., Carnec A., Carvunis A.-R., Pulak R., Shingles J., Reece-Hoyes J., Hunt-Newbury R., Viveiros R., Mohler W. A., Tasan M., Roth F. P., Le Peuch C., Hope I. A., Johnsen R., Moerman D. G., Barabási A.-L., Baillie D., Vidal M., Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nature Biotechnology 2007 25 6 663 668 2-s2.0-34250173488 10.1038/nbt1305 (Pubitemid 46897203)
39. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
40. Huang D. W., Sherman B. T., Lempicki R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009 37 1 1 13 2-s2.0-58549112996 10.1093/nar/gkn923
41. Gustin M.-P., Paultre C. Z., Randon J., Bricca G., Cerutti C., Functional meta-analysis of double connectivity in gene coexpression networks in mammals. Physiological Genomics 2008 34 1 34 41 2-s2.0-47249163800 10.1152/ physiolgenomics.00008.2008
42. Wang Y. J., Neurology Clinical Rating Scale 2005 Beijing, China Beijing China Friendship Publishing Company Press
43. Calin G. A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S. E., Iorio M. V., Visone R., Sever N. I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.-G., Kipps T. J., Negrini M., Croce C. M., A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 2005 353 17 1793 1801 2-s2.0-27244434788 10.1056/NEJMoa050995 (Pubitemid 41549891)
44. Eder M., Scherr M., MicroRNA and lung cancer. The New England Journal of Medicine 2005 352 23 2446 2448 2-s2.0-20344367792 10.1056/NEJMcibr051201 (Pubitemid 40958446)
45. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell 2005 120 1 15 20 2-s2.0-11844278458 10.1016/j.cell.2004.12.035 (Pubitemid 40094598)
46. Sonkoly E., Ståhle M., Pivarcsi A., MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Seminars in Cancer Biology 2008 18 2 131 140 2-s2.0-40449098091 10.1016/j.semcancer.2008. 01.005
47. Jia W., Gao W.-Y., Yan Y.-Q., Wang J., Xu Z.-H., Zheng W.-J., Xiao P.-G., The rediscovery of ancient Chinese herbal formulas. Phytotherapy Research 2004 18 8 681 686 2-s2.0-4944262480 10.1002/ptr.1506 (Pubitemid 39329723)
48. Chen L., Liu R., Liu Z.-P., Li M., Aihara K., Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Scientific Reports 2012 2, article 342 2-s2.0-84859741480 10.1038/srep00342
49. Dewey F. E., Perez M. V., Wheeler M. T., Watt C., Spin J., Langfelder P., Horvath S., Hannenhalli S., Cappola T. P., Ashley E. A., Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circulation 2011 4 1 26 35 2-s2.0-79952794409 10.1161/CIRCGENETICS.110.941757
50. Krek A., Grün D., Poy M. N., Wolf R., Rosenberg L., Epstein E. J., MacMenamin P., Da Piedade I., Gunsalus K. C., Stoffel M., Rajewsky N., Combinatorial MicroRNA target predictions. Nature Genetics 2005 37 5 495 500 2-s2.0-20944450160 10.1038/ng1536 (Pubitemid 40617277)
51. Jérôme T., Laurie P., Louis B., Pierre C., Enjoy the silence: the story of let-7 MicroRNA and cancer. Current Genomics 2007 8 4 229 233 2-s2.0-34547800649 10.2174/138920207781386933 (Pubitemid 47232963)